Subscribe To
Ultragenyx launches evkeeza® (evinacumab for injection) in canada for the treatment of homozygous familial hypercholesterolemia (hofh)
evkeeza is a first-in-class medicine approved by Health Canada, the U.S. Food and Drug Administration (...
September 25, 2023, 9:13 pm
Regeneron (regn) gets label extension for cholesterol drug
Regeneron (REGN) gets FDA approval for evkeeza to treat children aged 5 to 11 with homozygous familial ...
March 22, 2023, 4:01 pm
Regeneron's (regn) sbla for evkeeza gets fda priority review
The FDA accepts for priority review Regeneron's (REGN) sBLA for evkeeza for treating children aged five...
December 1, 2022, 9:47 am